US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cerenome, Inc

1.61

-0.0300-1.83%

Volume:34.18K

Turnover:56.19K

Market Cap:12.18M

PE:-0.37

High:1.69

Open:1.64

Low:1.60

Close:1.64

52wk High:20.25

52wk Low:1.49

Shares:7.59M

Float Shares:6.46M

Volume Ratio:0.26

T/O Rate:0.53%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.3700

EPS(LYR):-7.2500

ROE:-614.05%

ROA:-135.36%

PB:2.23

PE(LYR):-0.22

Loading ...

Overview Company News Filings

Cerenome Secures In-Network Reimbursement Agreement with Florida Blue for CNSide Tests

Cerenome Secures In-Network Agreement with Florida Blue for Cnside® Csf Tumor Cell Enumeration and Molecular Profile Tests

THOMSON REUTERS

Cerenome Price Target Cut to $31.00/Share from $50.00 by Lake Street

Cerenome Expects Q3 CNSide Gross Billings of $1.55 Million

Cerenome Unit CNSide Diagnostics Sets Sept. 30 CNSide Business Update Call

Cerenome Signs In-Network Deal with Blue Cross Blue Shield of Michigan for CNSide Test

Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding Cnside® Contracted Coverage to Approximately 158 Million Covered Lives

THOMSON REUTERS

Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, Cnside Diagnostics Division

THOMSON REUTERS

Press Release: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division

Cerenome Price Target Cut to $43.00/Share from $57.00 by Ascendiant Capital

Cerenome Secures up to $20 Million Senior Secured Facility from 3i Fund with Royalty-Based Repayment

Cerenome Announces up to $20 Million Financing Facility with Royalty-Based Repayment

THOMSON REUTERS

Calendar of U.S. Earnings Expected in the Week Ahead

Cerenome Q2 EPS $(1.31) Misses $(0.85) Estimate, Sales $411.000K Miss $1.110M Estimate

Benzinga Earnings

Plus Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Press Release: Cerenome Reports Second Quarter 2026 Financial Results and Business Update

Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding Cnside® Contracted Coverage to over 150 Million Covered Lives

THOMSON REUTERS

Plus Therapeutics Inc Expected to Post a Loss of 91 Cents a Share - Earnings Preview

Plus Therapeutics Amends Bylaws to Reflect Corporate Name Change to Cerenome

Plus Therapeutics to Trade on NASDAQ as Cerenome Under CNSY Ticker from Aug. 3

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/CNSY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CNSY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSY\",,,,,undefined,":{"symbol":"CNSY","market":"US","secType":"STK","nameCN":"Cerenome, Inc","latestPrice":1.605,"timestamp":1791474563213,"preClose":1.635,"halted":0,"volume":34180,"delay":0,"changeRate":-0.018348623853211024,"floatShares":6457200,"shares":7589600,"eps":-4.37005,"marketStatus":"Trading","change":-0.03,"latestTime":"10-08 11:50:01 EDT","open":1.64,"high":1.6875,"low":1.6,"amount":56188.344772,"amplitude":0.053517,"askPrice":1.66,"askSize":200,"bidPrice":1.62,"bidSize":90,"shortable":3,"etf":0,"ttmEps":-4.37005,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"listingDate":1134968400000,"exchange":"NASDAQ","adjPreClose":1.635,"preHourTrading":{"tag":"盘前","latestPrice":1.67,"preClose":1.635,"latestTime":"09:29 EDT","volume":830,"amount":1418.3314730000002,"timestamp":1791466199999,"change":0.035,"changeRate":0.021407,"amplitude":0.148685},"postHourTrading":{"tag":"盘后","latestPrice":1.635,"preClose":1.635,"latestTime":"19:30 EDT","volume":10,"amount":16.35,"timestamp":1791415801434,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.26159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSY\",,,,,undefined,":{"symbol":"CNSY","floatShares":6457200,"roa":"-135.36%","roe":"-614.05%","lyrEps":-7.25,"volumeRatio":0.26159,"shares":7589600,"dividePrice":0,"high":1.6875,"amplitude":0.053517,"preClose":1.635,"low":1.6,"week52Low":1.485,"pbRate":"2.23","psRate":"2.90","week52High":20.25,"institutionHeld":0.0916,"latestPrice":1.605,"committee":-0.37931,"eps":-4.37005,"divideRate":0,"volume":34180,"delay":0,"ttmEps":-4.37005,"open":1.64,"prevYearClose":12.8075,"prevWeekClose":1.6,"prevMonthClose":1.87,"prevQuarterClose":1.87,"fiveDayClose":1.78,"twentyDayClose":2.39,"sixtyDayClose":4.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNSY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"CNSY","fiscalQuarterEnding":"2026/06","expectedEps":-0.96,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":-1.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNSY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNSY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1775016000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNSY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNSY","date":"2026-10-07","current":-0.367273,"percent":0.978261,"low":-2.284561,"twenty":-1.818764,"median":-0.801496,"eighty":-0.580684,"high":-0.453841,"avg":-1.020377,"sd":0.625195,"marketCap":12067503},"quantilePoints":[{"date":"2026-08-07","current":-2.22687,"twenty":-2.261485,"median":-2.232639,"eighty":-2.18764,"marketCap":26568789},{"date":"2026-08-14","current":-2.134565,"twenty":-2.237254,"median":-2.212448,"eighty":-2.134565,"marketCap":25467492},{"date":"2026-08-21","current":-0.791526,"twenty":-2.228024,"median":-2.134565,"eighty":-0.843766,"marketCap":20649318},{"date":"2026-08-28","current":-0.901864,"twenty":-2.21764,"median":-1.50083,"eighty":-0.857767,"marketCap":23527837},{"date":"2026-09-04","current":-0.866953,"twenty":-2.210717,"median":-0.8975,"eighty":-0.843766,"marketCap":22617082},{"date":"2026-09-11","current":-0.695308,"twenty":-2.209563,"median":-0.887318,"eighty":-0.808178,"marketCap":18139203},{"date":"2026-09-18","current":-0.590576,"twenty":-2.164564,"median":-0.864044,"eighty":-0.761057,"marketCap":15406938},{"date":"2026-09-25","current":-0.544028,"twenty":-2.134565,"median":-0.844294,"eighty":-0.625487,"marketCap":14192598},{"date":"2026-10-02","current":-0.517845,"twenty":-2.072259,"median":-0.81652,"eighty":-0.590576,"marketCap":13509532},{"date":"2026-10-07","current":-0.462569,"twenty":-1.818764,"median":-0.801496,"eighty":-0.580684,"marketCap":12067503}],"updateTime":1791474601108},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNSY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673711230","title":"Cerenome Secures In-Network Reimbursement Agreement with Florida Blue for CNSide Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2673711230","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673711230?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:31","pubTimestamp":1791459076,"startTime":"0","endTime":"0","summary":"Cerenome secures in-network reimbursement agreement with Florida Blue for CNSide testsCerenome unit CNSide signed an in-network ancillary provider agreement with Florida Blue, effective Oct. 1, 2026.D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL2BvRq5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","BCDF","SG9999014005.SGD","CNSY","BK4588","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","SG9999014039.USD","LU2210149790.SGD","LU2095319765.USD","BK4139","IE00B64PRP62.GBP","IE00BQXX3D17.EUR","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4112","NDAQ","SG9999014021.USD","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","BK4585","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673719910","title":"Cerenome Secures In-Network Agreement with Florida Blue for Cnside® Csf Tumor Cell Enumeration and Molecular Profile Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2673719910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673719910?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:30","pubTimestamp":1791459000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA8WW3CJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672076686","title":"Cerenome Price Target Cut to $31.00/Share from $50.00 by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2672076686","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672076686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:16","pubTimestamp":1790871360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNSY/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671209346","title":"Cerenome Expects Q3 CNSide Gross Billings of $1.55 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2671209346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671209346?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:30","pubTimestamp":1790767849,"startTime":"0","endTime":"0","summary":"Cerenome expects Q3 CNSide gross billings of $1.55 millionCerenome projected Q3 2026 CNSide gross billings of USD 1.55 million from 222 tests billed at list prices.Annualized gross billing run rate ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL2W3Thv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014013.SGD","BK4585","IE00BQXX3D17.EUR","BK4588","IE00BN0W2T93.GBP","NDAQ","BK4139","LU2210149790.SGD","CNSY","IE00BGHQF748.EUR","BCDF","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BQXX3F31.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670424634","title":"Cerenome Unit CNSide Diagnostics Sets Sept. 30 CNSide Business Update Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2670424634","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670424634?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335824,"startTime":"0","endTime":"0","summary":"Cerenome unit CNSide Diagnostics sets Sept. 30 CNSide business update callCNSide Diagnostics, a wholly owned unit of Cerenome, will host a CNSide business update call on Sept. 30, 2026.Update centers ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nNDL1Hlwr9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BCDF","CNSY","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","BK4139","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669214998","title":"Cerenome Signs In-Network Deal with Blue Cross Blue Shield of Michigan for CNSide Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2669214998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669214998?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:30","pubTimestamp":1790076643,"startTime":"0","endTime":"0","summary":"Cerenome signs in-network deal with Blue Cross Blue Shield of Michigan for CNSide testCerenome signed an in-network provider agreement with Blue Cross Blue Shield of Michigan for its CNSide CSF tumor ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL9TRmhN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","CNSY","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","LU2095319765.USD","NDAQ","LU0314104364.USD","BK4112","BK4585","IE00BKPKM429.USD","BCDF","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","SG9999014039.USD","BK4139","IE00B64PRP62.GBP","SG9999014005.SGD","BK4588","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669624149","title":"Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding Cnside® Contracted Coverage to Approximately 158 Million Covered Lives","url":"https://stock-news.laohu8.com/highlight/detail?id=2669624149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669624149?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:30","pubTimestamp":1790076600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA2KMNQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNSY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667002346","title":"Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, Cnside Diagnostics Division","url":"https://stock-news.laohu8.com/highlight/detail?id=2667002346","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667002346?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:30","pubTimestamp":1789558200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA2X45LW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNSY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667403600","title":"Press Release: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division","url":"https://stock-news.laohu8.com/highlight/detail?id=2667403600","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667403600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:30","pubTimestamp":1789558200,"startTime":"0","endTime":"0","summary":"HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) (\"Cerenome\" or the \"Company\"), today announces the appointment of Samant","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","BK4588","CNSY","R","XT","03160","BK4232","BK4585","BK4139","BK4604","BK4022","TM","BK4099","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666253295","title":"Cerenome Price Target Cut to $43.00/Share from $57.00 by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666253295","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666253295?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:11","pubTimestamp":1789121460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNSY/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560193","title":"Cerenome Secures up to $20 Million Senior Secured Facility from 3i Fund with Royalty-Based Repayment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560193?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:15","pubTimestamp":1789038936,"startTime":"0","endTime":"0","summary":"Cerenome secures up to $20 million senior secured facility from 3i Fund with royalty-based repaymentCerenome entered a senior secured financing agreement with 3i Fund for a facility of up to USD 20 mi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL2WzxDy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4585","SG9999014039.USD","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4139","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","IE00BQXX3C00.GBP","BCDF","LU2210150020.SGD","BK4112","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0314104364.USD","CNSY","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560156","title":"Cerenome Announces up to $20 Million Financing Facility with Royalty-Based Repayment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560156?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:15","pubTimestamp":1789038900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA9WY85K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660891784","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2660891784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660891784?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:00","pubTimestamp":1786960800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Amer Sports Inc.                                  2Q       .11    6:00 AM. ·Home Depot Inc.                                   2Q      4.73    6:00 AM. ·Pony AI ADR                                     2Q      (.15)   5:00 AM. ·BILL Hldgs Inc                                  4Q       .71    4:01 PM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BABA","ANF","BEEM","HSAI","BMA","HD","ALVO","XP","DCGO","JKHY","ADI","FN","HAIN","AAP","ANVS","HTHT","MBRX","NDSN","DOMO","BILL","FBRX","FLNG","KEYS","LYTS","FLUX","MRCY","EL","AS","BEKE","ADIL","LZB","ZTO","LONA","LOW","IMTX","GGAL","CAAP","BJ","DE","IQ","FLO","ATHM","MRKR","CNSY","BIDU","FUTU","KLAR","KC","ATAT","COTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659041121","title":"Cerenome Q2 EPS $(1.31) Misses $(0.85) Estimate, Sales $411.000K Miss $1.110M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659041121","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659041121?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:12","pubTimestamp":1786741958,"startTime":"0","endTime":"0","summary":"Cerenome (NASDAQ:CNSY) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate of $(0.85) by 54.12 percent. This is a 718.75 percent decrease over losses of $(0.16) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61231587/cerenome-q2-eps-1-31-misses-0-85-estimate-sales-411-000k-miss-1-110m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cerenome Q2 EPS $(1.31) Misses $(0.85) Estimate, Sales $411.000K Miss $1.110M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659412153","title":"Plus Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659412153","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659412153?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:46","pubTimestamp":1786740367,"startTime":"0","endTime":"0","summary":"Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryPlus Therapeutics IncCNSY.OQreported a quarterly adjusted loss of $1.31 per share for the quarter ended June 30, l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B1KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659412930","title":"Press Release: Cerenome Reports Second Quarter 2026 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659412930","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659412930?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:15","pubTimestamp":1786738500,"startTime":"0","endTime":"0","summary":"August 3, 2026, with the Company's common stock trading on the Nasdaq. Capital Market under the ticker symbol \"CNSY\"REYOBIQ Development-- Continued enrollment in the ReSPECT-LM multiple-dose clinical trial. As. of June 30, 2026, approximately one-third of patients had been enrolled,with no dose-limiting toxicities observed to date, supporting the. development of a recommended Phase 2 dose/dosing regimen by year-end. -- Continued enrollment in the ReSPECT-GBM Phase 2 trial. Current enrollment. rates indicate full enrollment in 2026 followed by a data readout and a. subsequent End-of-Phase 2 meeting with the U.S. Food and Drug. -- Initial site activation of the ReSPECT-PBC pediatric brain cancer Phase 1. trial at Lurie Children's Hospital. First dosing expected in the third. -- Continued commercial-level manufacturing scale-up and supply chain. enhancement for REYOBIQ drug supplyCNSide CSF Assay Platform-- Performed 232 CNSide cerebrospinal fluid tests during the first half of. 2026 and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","R","BK4604","03160","LCLG","NCI","TM","BK4232","BK4022","BK4585","CNSY","BK4202","BK4588","BK4555","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159181","title":"Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding Cnside® Contracted Coverage to over 150 Million Covered Lives","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159181?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUAB71BNS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893993","title":"Plus Therapeutics Inc Expected to Post a Loss of 91 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893993","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893993?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:49","pubTimestamp":1786366145,"startTime":"0","endTime":"0","summary":"Plus Therapeutics Inc <CNSY.OQ> expected to post a loss of91cents a share - Earnings PreviewPlus Therapeutics IncCNSY.OQCNSY.Ois expected to  show a fall in quarterly revenue when it reports  results ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44710O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNSY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657876560","title":"Plus Therapeutics Amends Bylaws to Reflect Corporate Name Change to Cerenome","url":"https://stock-news.laohu8.com/highlight/detail?id=2657876560","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657876560?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:33","pubTimestamp":1785879239,"startTime":"0","endTime":"0","summary":"Plus Therapeutics amends bylaws to reflect corporate name change to CerenomePlus Therapeutics amended its bylaws to reflect a corporate name change to Cerenome, effective Aug. 3, 2026.Nasdaq trading s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL2PyX3w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655366725","title":"Plus Therapeutics to Trade on NASDAQ as Cerenome Under CNSY Ticker from Aug. 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2655366725","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655366725?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:32","pubTimestamp":1785501155,"startTime":"0","endTime":"0","summary":"Plus Therapeutics to trade on Nasdaq as Cerenome under CNSY ticker from Aug. 3Plus Therapeutics will complete its rebrand to Cerenome on Aug. 3, 2026.Nasdaq Capital Market trading will switch to ticke","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL6DlsRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDF","BK4585","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","BK4588","LU2210150020.SGD","BK4112","CNSY","NDAQ","PSTV","LU0314104364.USD","SG9999014013.SGD","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}